Dr. Reddy's Laboratories Limited (RDDA) — Cash Flow Quality Index
Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Quality Index of 0.90x as of December 2025. Operating cash flow of €10.91 Billion is below net income of €12.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore RDDA operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Dr. Reddy's Laboratories Limited Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Dr. Reddy's Laboratories Limited across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check RDDA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year earnings quality comparison for Dr. Reddy's Laboratories Limited. For live market cap and the full company financial profile, see how much is Dr. Reddy's Laboratories Limited worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | €46.43 Billion | €56.54 Billion | ▲ +0.8% |
| 2024 | 0.81x | €45.43 Billion | €55.78 Billion | ▼ -37.7% |
| 2023 | 1.31x | €58.88 Billion | €45.07 Billion | ▲ +9.5% |
| 2022 | 1.19x | €28.11 Billion | €23.57 Billion | ▼ -36.0% |
| 2021 | 1.86x | €35.70 Billion | €19.15 Billion | ▲ +21.8% |
| 2020 | 1.53x | €29.84 Billion | €19.50 Billion | ▲ +0.2% |
| 2019 | 1.53x | €28.70 Billion | €18.80 Billion | ▼ -16.9% |
| 2018 | 1.84x | €18.03 Billion | €9.81 Billion | ▲ +2.9% |
| 2017 | 1.79x | €21.51 Billion | €12.04 Billion | — |